ConditionHelicobacter Pylori Infection
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-80
SponsorSichuan Provincial People's Hospital
About this trial
To determine whether regulating the gut microbiota can contribute to the eradication of refractory H. pylori infection.
Eligibility criteria
Qualifiers
1. Ages 18-70
2. Hp infection treatment failed ≥4 times with guidelines-recommended therapies
3. Patients with early gastric cancer, peptic ulcer, gastric MALT lymphoma, atrophic gastritis and other diseases requiring the eradication of Hp.
Disqualifiers
1. Antibiotics and bismuth were taken within 4 weeks before this treatment; Or had taken PPI, H2 receptor antagonist, P-CAB within 2 weeks prior to treatment;
2. Pregnant or lactating women;
3. Those who are allergic to the investigational drugs used in this test or have contraindications;
4. Participated in other drug trials within 3 months before the treatment of this trial;
Trial design
Treatments tested in this trial
- transanal fecal bacteria transplant
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov